Profiles from former judges.
Francesco Bandello is Professor and Chairman of the Department of Ophthalmology at the University Vita-Salute, Milan, Italy. He is a member of the Academia Ophthalmologica Internationalis and the vice president of Academia Ophthalmologica Europea. He has been a peer reviewer for National Institutes of Health grant applications since 2006.
Professor Bandello is the associate editor of the European Journal of Ophthalmology and co-editor of Developments in Ophthalmology. He also serves on the editorial boards of several other ophthalmology journals.
Professor Bandello's scientific interests include the study of new therapeutic agents for the inhibition of angiogenesis in cases of proliferative diabetic retinopathy and age-related macular degeneration, biomarkers in age-related macular degeneration, and correlation between systemic and ophthalmic vascular diseases. He is also interested in medical robotics and bioengineering in the study of the retina.
Professor Bandello has been the principal investigator in several clinical trials concerning diabetic retinopathy and age-related macular degeneration. He is co-author of nine books and has published more than 416 articles in journals listed on Pub-Med relating to retinal diseases, diabetic retinopathy, age-related macular degeneration, and fluorescein and indocyanine green angiographies of different retinal vascular disorders.
Professor Nicole Eter completed her residency in 1999, and worked as an attending physician at the Department of Ophthalmology, University of Bonn Medical Centre. She acquired her postdoctoral lecturer's qualification in 2002, and became Professor of Ophthalmology in 2007. In 2010 Professor Eter was appointed Department Chair and Medical Director of the Department of Ophthalmology, University of Münster, where she specialises in vitreoretinal surgery and medical retina, while covering the whole scope of ophthalmologic surgical procedures.
Her main research interests are age-related macular degeneration, anti-angiogenic therapies, molecular imaging and nanotechnology in ophthalmology, diagnosis and treatment of medical and surgical retina, cornea and glaucoma, and surgery.
Richard Gale is a Consultant Medical Ophthalmologist practicing at York Teaching Hospital. He trained in Yorkshire, Cambridge, Moorfields Eye Hospital and, for a short period, Boston, USA. His interests are in medical disorders of the retina and inflammatory eye disease. He has been awarded 'best clinical service' by the Macular Society.
Mr Gale has been the chief or principle investigator in around 20 research studies, recruiting over 500 participants, and has published around 50 papers or book chapters. He has been awarded a number of personal grants for research.
Mr Gale has a keen interest in education, chairing the Medical Ophthalmology Specialist Advisory Committee and National Assessment panel for the Medical Royal Colleges. He is an Honorary Senior Lecturer at the Hull and York Medical School.
Paul Harasymowycz heads the glaucoma research unit at the University of Montreal and has served as clinician and researcher at the Maisonneuve-Rosemont Hospital and the Guy-Bernier Research Centre since 2011. He is medical director of the Bellevue Ophthalmology Clinics and the Montreal Glaucoma Institute. He is also medical director of the Quebec Glaucoma Foundation, an organization dedicated to promoting glaucoma research in Quebec, increasing public awareness of the disease and educating people who suffer from the illness.
Dr Harasymowycz's research focuses on glaucoma screening, new diagnostic technologies and new surgical treatments for glaucoma and cataracts. He has a passion for teaching students, residents and glaucoma fellows and is often invited to present and teach surgical techniques at national and international conferences. He is a member of the Glaucoma Committee of the American Society of Cataract and Refractive Surgery (ASCRS) and sits on the board of directors of the Association des Médecins Ophtalmologistes du Québec (Quebec's association of ophthalmologists). He has published over fifty articles in peer-reviewed medical journals as well as book chapters on glaucoma.
Frank G. Holz is Professor and Chairman of the Department of Ophthalmology at the University of Bonn. His major clinical interest is surgical and medical retina. His scientific interests include the pathogenesis, prognostic factors, biomarkers and treatment of macular and retinal diseases, and innovative retinal imaging technologies. He was trained at the University of Heidelberg, Germany, and passed a fellowhip at Moorfields Eye Hospital, London, with Professor Alan C. Bird.
Professor Holz has been a cofounder of the Priority Program AMD of the German Research Council (DFG) and the GRADE Reading Center Bonn. He is a Board Member of the of the German Ophthalmological Society (DOG) and EURETINA, a Member of the European Academy of Ophthalmology, the Macula Society, the Club Jules Gonin, Editor-in-Chief of Der Ophthalmologe, and serves as a reviewer for many peer reviewed journals. He has received numerous awards, including the Leonhard-Klein Award for Ocular Surgery, the Alcon Research Institute (ARI) Award, and the Senior Achievement Award of the AAO. Professor Holz has published more than 300 articles in peer-reviewed journals and is editor of several books on retinal diseases.
Lyndon Jones is a Professor at the School of Optometry and Vision Science, University Research Chair and Director of the Centre for Contact Lens Research at the University of Waterloo, Canada. He graduated in Optometry from the University of Wales in 1985 and gained his PhD in Chemical Engineering from the Biomaterials Research Unit at Aston University, Birmingham, UK in 1998. His research interests primarily focus on the interaction of novel and existing contact lens materials with the ocular environment, dry eye and ocular drug delivery. He has authored over 300 refereed and professional papers and one text book, and given over 900 invited scientific and continuing education lectures at conferences in over 30 countries worldwide. He has been awarded over 30 national and international awards, including the 2014 'Glenn Fry Award' from the American Academy of Optometry (AAO), the 2014 'Donald Korb Award' from the American Optometric Association and the 2013 'Max Schapero Award' from the Cornea and Contact Lens Section of the AAO.
Paolo Lanzetta is Chairman of the Department of Ophthalmology at the University of Udine, Italy, where his main interests include laser applications in ophthalmology; diagnosis and treatment of vitreous, retinal and macular diseases; and cataract surgery. Professor Lanzetta is also actively involved in retinal clinical research focusing on photodynamic therapy, anti-angiogenic treatments, and new drugs and delivery systems. Professor Lanzetta is a member of numerous professional societies, including ARVO and the Macula Society, and has given over 350 presentations at national and international meetings. As well as publishing over 170 original articles, Professor Lanzetta is a scientific reviewer for many journals, and serves on the Editorial Board of the European Journal of Ophthalmology.
Xiaoxin Li is Chairperson and Professor for the Eye Center and Eye Institute of Peking University People's Hospital. She is an academic committee member of Peking University Health Science Center and former Dean of Ophthalmology Faculty of Peking University Science Center. She is currently Past President of the Chinese Ophthalmology Society (COS) and President of the Chinese Ocular Fundus Society (Vitreo-Retina Society). Last year, Professor Li accepted the position of Director of Ophthalmology at the Health Human Resources Development Center, and oversees the national evaluation exam for Ophthalmologists in China. She served as a member of the American Academy of Ophthalmology's Global Advisors Committee from 2007 to 2011, and was a board member of the International Council of Ophthalmology from 2010 to 2012.
Professor Li has contributed significantly to ophthalmic training and education, especially in the vitreo-retinal area within China. She has organized numerous lectures, seminars, workshops, and courses on this topic, over the past two decades. Professor Li is also an advocate of improving training materials, and has written and edited several ophthalmology books. Professor Li has authored or co-authored more than 200 papers in both Chinese and international journals, and is the Editor in Chief of the journal 'Retina'.
Professor Anat Loewenstein is Professor of Ophthalmology, Incumbent of The Sydney A. Fox Chair in Ophthalmology and Vice Dean of the Sackler Faculty of Medicine, Tel Aviv University, and Director of the Department of Ophthalmology, Tel Aviv Medical Center in Tel Aviv, Israel.
After medical studies at the Hebrew University in Jerusalem and residency in the Department of Ophthalmology at the Tel Aviv Medical Center, Professor Loewenstein completed a fellowship in retinal vascular diseases and vitreoretina surgery at the Wilmer Eye Institute, Johns Hopkins University Hospital, Baltimore, Maryland.
Professor Loewenstein's main areas of expertise including age-related macular degeneration, specifically early detection and treatment modalities, retinal vascular occlusions, and investigation of drug toxicity in the retina. She has also been the leader behind the development of model technology for early detection of macular degeneration. Professor Loewenstein has published extensively in peer reviewed journals and ophthalmology textbooks, and as well as being member of several national and international ophthalmological societies, Professor Loewenstein participates in numerous national and international meetings each year, frequently as an invited speaker.
Tom Sheidow is Associate Professor of the Department of Ophthalmology at the University of Western Ontario, London, Canada. As an active member of the Canadian Retinal Trials Group, Dr Sheidow's major clinical and research interests are age-related macular degeneration, other macular diseases, and teleophthalmology and its application to patient screening and referral; he has been a participant in several of the major age-related macular degeneration and diabetes clinical trials over recent years.
Professor Sheidow is also the co-chair for a current Canadian trial evaluating effective treatments for diabetic macular edema. Professor Sheidow is a Fellow of the Royal College of Physicians and Surgeons of Canada, a member of the Canadian Ophthalmology Society, and editor of the retina section for the Canadian Journal of Ophthalmology. He has published articles in many journals, including Ophthalmology, Retina and Canadian Journal of Ophthalmology.